ENDPOINTS

Belgian biotech Augustine gets $85M for neuro and cardiometabolic pills

Augustine Therapeutics has reeled in €77.7 million (about $85 million) to take on Charcot-Marie-Tooth disease, neurodegenerative conditions and cardiometabolic disorders. Two of Europe's leading biotech investment firms — Novo Holdings and Jeito Capital — co-led the Series ...

Mar 24, 2025 - 07:02
 0
Belgian biotech Augustine gets $85M for neuro and cardiometabolic pills
Augustine Therapeutics has reeled in €77.7 million (about $85 million) to take on Charcot-Marie-Tooth disease, neurodegenerative conditions and cardiometabolic disorders. Two of Europe's leading biotech investment firms — Novo Holdings and Jeito Capital — co-led the Series ...
Read More

Tags:

Previous Article

Ocean sediments from Bay of Bengal reveal insights into Indian Monsoon patterns,...

Next Article

2 ways to strengthen SBTi’s new net zero draft

Related Posts

Repare to lay off 75% of staff; Castle Creek inks $75M royalty deal

Repare to lay off 75% of staff; Castle Creek inks $75M ...

Feb 25, 2025  0

Exclusive: Lithuanian biotech Atrandi Biosciences raises $25M Series A

Exclusive: Lithuanian biotech Atrandi Biosciences raise...

Feb 18, 2025  0

Emalex clears Phase 3 for Tourette syndrome, will seek FDA approval

Emalex clears Phase 3 for Tourette syndrome, will seek ...

Feb 25, 2025  0